The U.S. health regulator has approved GSK's add-on drug to treat severe asthma, the drugmaker said on Tuesday, paving the ...

Former Vice President Mike Pence’s organization says Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. “must go ...

Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become the most ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche ...

President Donald Trump said Monday that the White House is “very strongly” considering signing an executive order to ...

French drugmaker Sanofi on Monday flagged another delay to a U.S. regulatory decision for its experimental multiple sclerosis ...

Farm kids tend to have far fewer allergies than city kids, and a new study offers one possible explanation: The milk provided ...

On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...

The drugs are essentially laboratory-made versions of natural antibodies that help the immune system fight off RSV. The FDA ...

GSK Plc said it won US approval for a drug to treat severe asthma, boosting its prospects as a potential blockbuster.

The move wouldn't legalize marijuana, but moving it from Schedule I to Schedule III would allow the FDA to study it for ...

Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been ...